摘要
目的：探讨玻璃体手术治疗增殖性糖尿病视网膜病变的效果.方法：对86例104眼行玻璃体切除术的增殖性糖尿病视网膜病变患者的临床资料进行回顾性分析.结果：术后随访3～24个月,术后矫正视力改善82眼（78.5％）.其中Ⅳ期～V期62眼（75.6％）,Ⅵ期20眼（24.4％）;19眼（18.3％）视力不变,其中Ⅳ期～V期2眼（10.5％）,Ⅵ期17眼（89.5％）;3眼术后视力下降,其中Ⅳ期～V期1眼（33.3％）,Ⅵ期2眼（66.7％）.视力≥0.1者由术前12只眼（11.5％）增加到术后39眼（37.5％）.Ⅳ期、V期患眼术后视力改善程度明显好于Ⅵ期者,差异有统计学意义（P＜0.01）.结论：玻璃体切除术是治疗PDR的有效方法,但PDR的严重程度不同对术后视力恢复有不同的影响,早期手术效果更佳.
Objective： To study the effect of vitrectomy on proliferative diabetic retinopathy（PDR）. Methods： 86 cases（104eyes） of PDR treated with vitrectomy were studied retrospectively. Results： Following up for 3-24 months after operation, correct visual acuity improved in 82 eyes （78.5%） including 62 eyes （75.6%） with IV- V stage PDR and 20 eyes （24,4%） with VI stage PDR;no changes in VA was found in 19 eyes（ 18.3% ） including 2 eyes（ 10.5% ） with IV-V stage PDR,and 17 eyes（89.5%） with VI stage PDR;VA decreased were 12 eyes including 1 eye（33.3%） with IV-Vstage PDR,and 2 eyes（66.7%） with VI stage PDR;the number of eyes with VA≥0.1were increased from 12（11.5%） to 39（37.5%）.VA of IV-V stage PDR improved obviously than that of VI stage PDR in which the difference was statistically significant （P〈0.01）.Conelusion：Vitreetomy is an effective treatment for PDR in which the different stage of the PDR can have the different affect on VA, and early vitrectomy is better.
出处
《甘肃医药》
2013年第12期895-897,共3页
Gansu Medical Journal
